日本語のみで絞り込む
Meet Moderna. Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines. Learn more ...
Moderna COVID-19 Vaccine - FDA
- https://www.fda.gov
- moderna-covid-19-vaccine
- https://www.fda.gov
- moderna-covid-19-vaccine
The Moderna COVID-19 Vaccine (2023-2024 Formula) includes a monovalent (single) component that corresponds to the Omicron variant XBB.1.5 of SARS-CoV-2. The ...
U.S. COVID-19 Vaccine Product Information | CDC
- https://www.cdc.gov
- covid-19
- info-by-product
- https://www.cdc.gov
- covid-19
- info-by-product
People ages 18 years and older who received 1 or 2 Janssen COVID-19 Vaccine dose are recommended to receive 1 bivalent mRNA dose (Moderna or Pfizer-BioNTech) ...
Moderna - Wikipedia
- https://en.wikipedia.org
- wiki
- Moderna
- https://en.wikipedia.org
- wiki
- Moderna
Moderna, Inc is a pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines.
COVID-19 vaccine-Noubar Afeyan-Stéphane Bancel-Derrick Rossi
Moderna (@moderna_tx) / X
- https://twitter.com
- moderna_tx
- https://twitter.com
- moderna_tx
Our mission is to deliver the greatest possible impact to people through mRNA medicines.
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA).
At Moderna, we believe messenger RNA, or mRNA, is the “software of life.” Every cell in the body uses mRNA to provide real-time instructions to make the ...
モデルナ
モデルナ（Moderna [məˈdɜːrnə]）は、アメリカ合衆国マサチューセッツ州ケンブリッジに本社を置くバイオテクノロジー企業。メッセ...-Wikipedia
- 株価125.67ドル
5月13日20時00分（現地時間） 現在-ご注意 - 時価総額48,161,736千ドル
- 代表者Stéphane Bancel
- 本部所在地ケンブリッジ
- 設立2016年7月22日